# PRIFTIN
> **NDA021024** · New Drug Application · Sponsor: SANOFI AVENTIS US · Approved 1998-06-22
## Drug
- **FDA Application Number:** NDA021024
- **Application type:** New Drug Application
- **Brand name:** PRIFTIN
- **Generic name:** RIFAPENTINE
- **Active ingredients:** RIFAPENTINE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** SANOFI AVENTIS US
- **Manufacturer:** sanofi-aventis U.S. LLC
- **First approval:** 1998-06-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021024)
---
*AI Analytics · CC0 1.0*